EXELAN PHARMACEUTICALS INC. holds $189.0M across 124 federal awards, concentrated at Department of Veterans Affairs (VA). Competition previously drew 2 offers. Recompete timing centers on the Jan 14, 2027 PoP end — agencies typically plan 12–18 months ahead.
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
Current PoP ends Jan 14, 2027 (171 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Track recompete timing in SCOUT →EXELAN PHARMACEUTICALS INC. — $189.0M obligated across 124 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. Free — no card required.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open EXELAN PHARMACEUTICALS INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Register free to start exploring SCOUT →